Biomarkers of Alzheimer's Disease: An Overview of the Recent Inventions
The etiology of Alzheimer's disease (AD) is complex which includes oxidative stress, apoptosis, mutations in genes, imbalance in metal homeostasis and neuroinflammation. Biomarkers such as micro RNAs, peptides, protein complexes and genes in various body fluids of AD patients play a pivotal role not only in diagnosis of the disease but also in following the therapeutic effects of drugs employed to treat this neurodegenerative disorder. However, there has been a substantial dearth in diagnosing this disease at the earliest. This review focuses on recent advances and patents in the field of biomarkers of AD. It strongly emphasizes the growing need to translate the available and upcoming knowledge into substantial clinical trials to streamline a vital armamentarium for the disease.
No Supplementary Data
No Article Media
Document Type: Research Article
Publication date: September 1, 2013
More about this publication?
- Recent Patents on Biomarkers publishes review and research articles, and guest edited thematic issues on important recent patents on biomarkers. The coverage includes novel biomarkers in basic, medical, environmental, and pharmaceutical research. A selection of important and recent patents on biomarkers is also included in the journal. The journal is essential reading for all researchers involved in biomarker research and discovery. The journal also covers recent research (where patents have been registered) in fast emerging patent biomarker applications; discovery and validation are covered for drug discovery, clinical development and molecular diagnostics.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Ingenta Connect is not responsible for the content or availability of external websites